How to buy MGC Pharmaceuticals shares | 31 March price A$0.062

How to buy MGC Pharmaceuticals shares | A$0.062

Own MGC Pharmaceuticals shares in just a few minutes. Share price changes are updated daily.

MGC Pharmaceuticals Limited (MXC) is a leading drug manufacturers-specialty and generic business based in Australia. It opened the day at A$0.063 after a previous close of A$0.064. During the day the price has varied from a low of A$0.06 to a high of A$0.063. The latest price was A$0.062 (25 minute delay). MGC Pharmaceuticals is listed on the Australian Securities Exchange (ASX). All prices are listed in Australian Dollars.

How to buy shares in MGC Pharmaceuticals

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: MXC in this case.
  5. Research MGC Pharmaceuticals shares. The platform should provide the latest information available.
  6. Buy your MGC Pharmaceuticals shares. It's that simple.
The whole process can take as little as 15 minutes.

MGC Pharmaceuticals share price

Use our graph to track the performance of MXC stocks over time.

MGC Pharmaceuticals shares at a glance

Information last updated 2021-03-31.
OpenA$0.063
HighA$0.063
LowA$0.06
CloseA$0.062
Previous closeA$0.064
Change A$-0.002
Change % -3.125%
Volume 10,983,395
Information last updated 2021-03-24.
52-week rangeA$0.017 - A$0.13
50-day moving average A$0.0691
200-day moving average A$0.0358
Wall St. target priceA$0.11
Dividend yield N/A (0%)
Earnings per share (TTM) A$-0.002
Promoted
eToro Free Stocks

Invest in MGC Pharmaceuticals shares with 0% commission

Other fees may apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • If your trades get copied you can earn extra money
  • Create an account today in a few minutes

Share dealing platform comparison

Table: sorted by promoted deals first
Data updated regularly
Name Product Ratings Finder rating Customer rating Min. initial deposit Price per trade Frequent trader rate Platform fee Table offer Link
OFFER
Fineco
We say
★★★★★
You say
★★★★★
We say
★★★★★
You say
★★★★★
£0
UK: £2.95
US: $3.95
EU: €3.95
N/A
£0
Your first 100 trades are free with Fineco (T&Cs apply)
Go to site

Capital at risk

Platform details
Hargreaves Lansdown Fund and Share Account
We say
★★★★★
You say
★★★★★
We say
★★★★★
You say
★★★★★
£1
£11.95
£5.95
£0
Go to site

Capital at risk

Platform details
FREE TRADES
eToro Free Stocks
We say
★★★★★
You say
★★★★★
We say
★★★★★
You say
★★★★★
$200
£0
N/A
£0
Go to site

Capital at risk

Platform details
FREE TRADES
Stake
We say
★★★★★
You say
★★★★★
We say
★★★★★
You say
★★★★★
£50
US: £0
N/A
£0
Join and receive a free share worth up to £100
Go to site

Capital at risk

Platform details
Degiro Share Dealing
We say
★★★★★
We say
★★★★★
Not yet rated
£0.01
UK: £1.75 + 0.014% (max £5)
US: €0.50 + $0.004 per share
N/A
£0
Go to site

Capital at risk

Platform details
loading

Compare up to 4 providers

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy MGC Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

MGC Pharmaceuticals price performance over time

Historical closes compared with the last close of A$0.062

1 week (2021-04-09) -8.82%
1 month (2021-03-19) -19.48%

Financials

Revenue TTM A$1 million
Gross profit TTM A$174,665
Return on assets TTM -58.25%
Return on equity TTM -414.1%
Profit margin 0%
Book value A$0.001
Market capitalisation A$163.2 million

TTM: trailing 12 months

MGC Pharmaceuticals share dividends

We're not expecting MGC Pharmaceuticals to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Have MGC Pharmaceuticals's shares ever split?

MGC Pharmaceuticals's shares were split on a 1:10 basis on 20 August 2012. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your MGC Pharmaceuticals shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for MGC Pharmaceuticals shares which in turn could have impacted MGC Pharmaceuticals's share price.

Share price volatility

Over the last 12 months, MGC Pharmaceuticals's shares have ranged in value from as little as A$0.017 up to A$0.13. A popular way to gauge a stock's volatility is its "beta".

MXC.AU volatility(beta: 1.72)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while MGC Pharmaceuticals's is 1.7187. This would suggest that MGC Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site